The innate and adaptive arms of the immune system are finely tuned to efficiently react to either endogenous or exogenous noxiae that perturb the function of our tissues and organs, thus rapidly returning to homeostasis with minimal collateral damage. The molecular mechanisms by which this occurs have been only partially elucidated. The work by Kanayama et al. 1 contributes to the building of this wall of knowledge by adding an important brick. They show that osteopontin (OPN), a phosphorylated protein of the extracellular matrix (ECM), has a dominant role in balancing lymphoid and myeloid cells during emergency granulopoiesis (that is, an increased cellular output from the bone marrow to meet the acute demand for the respective blood cell type). 2 OPN that is produced and released by bone marrow (BM) stromal cells negatively impacts the pool size of hematopoietic stem cells (that is, Lin − Sca-1 + c-kit + ). 3, 4 The role of OPN on myeloid and lymphoid progenitor cells was unknown. Kanayama et al. 1 clearly establish that in conditions that trigger emergency granulopoiesis (for example, irradiation, treatment with thioglycollate, C. albicans infection), intracellular OPN (iOPN) limits myeloid progenitor cells by exerting a proapoptotic role. While iOPN is not proapoptotic in neutrophils, monocytes or lymphoid progenitors, secreted osteopontin (sOPN) favors T-and B-cell expansion by inhibiting apoptosis. Thus, the net effect of OPN consists of decreasing the size of myeloid progenitors and increasing the size of lymphoid cells during demand-adapted myelopoiesis and lymphoid cell expansion in lymphopenic hosts.
The innate and adaptive arms of the immune system are finely tuned to efficiently react to either endogenous or exogenous noxiae that perturb the function of our tissues and organs, thus rapidly returning to homeostasis with minimal collateral damage. The molecular mechanisms by which this occurs have been only partially elucidated. The work by Kanayama et al. 1 contributes to the building of this wall of knowledge by adding an important brick. They show that osteopontin (OPN), a phosphorylated protein of the extracellular matrix (ECM), has a dominant role in balancing lymphoid and myeloid cells during emergency granulopoiesis (that is, an increased cellular output from the bone marrow to meet the acute demand for the respective blood cell type). 2 OPN that is produced and released by bone marrow (BM) stromal cells negatively impacts the pool size of hematopoietic stem cells (that is, Lin − Sca-1 + c-kit + ). 3, 4 The role of OPN on myeloid and lymphoid progenitor cells was unknown. Kanayama et al. 1 clearly establish that in conditions that trigger emergency granulopoiesis (for example, irradiation, treatment with thioglycollate, C. albicans infection), intracellular OPN (iOPN) limits myeloid progenitor cells by exerting a proapoptotic role. While iOPN is not proapoptotic in neutrophils, monocytes or lymphoid progenitors, secreted osteopontin (sOPN) favors T-and B-cell expansion by inhibiting apoptosis. Thus, the net effect of OPN consists of decreasing the size of myeloid progenitors and increasing the size of lymphoid cells during demand-adapted myelopoiesis and lymphoid cell expansion in lymphopenic hosts.
The authors started from the observation that in mixed BM chimeras (that is, lethally irradiated wild-type mice reconstituted with a 1:1 ratio of BM cells from OPN +/+ and OPN − / − mice), OPN − / − donor cells had larger myeloid cell populations and smaller lymphoid cell populations than OPN − / − donor cells in the BM, despite similar concentrations of serum OPN in wild-type mice and chimeras. Indeed, multipotent progenitors, common myeloid progenitors (CMPs) and granulocyte-macrophage progenitors (GMPs) were enriched, and common lymphoid progenitors (CLPs) were slightly decreased in the BM from OPN − / − mice, when compared to the BM of OPN +/+ mice. Thus, in irradiated recipient mice, iOPN in hematopoietic progenitor cells, and not sOPN, is responsible for decreasing the pool of myeloid progenitors.
To mimic emergency granulopoiesis, OPN +/+ and OPN − / − mice were treated with thioglycollate, which depletes neutrophils from the BM within 12 h (h) and causes enlargement and proliferation of CMP and GMP populations, but not of CLPs. Twenty-four hours after thioglycollate injection, OPN − / − mice had more GMPs and neutrophils in the BM than OPN +/+ mice, thus confirming that OPN restrains the expansion of myeloid precursors during the early stage of demand-adapted myelopoiesis.
How is iOPN regulated in myeloid precursors? Twenty-four hours after thioglycollate injection, neutrophil depletion in the BM of OPN +/+ mice was associated with increased sOPN and transiently decreased expression of the gene encoding OPN (Spp1) in GMPs. Modulation of iOPN depends on cellular density, because myeloid cells crowded at the bottom of round-bottom wells had more Spp1 mRNA than cells cultured in flat-bottom plates. Increased Spp1 mRNA was associated with activation of the Hippo pathway, 5 and inhibition of the Hippo pathway abolished the celldensity-mediated upregulation of iOPN. Additionally, blockade of E-cadherin, which triggers the Hippo pathway, decreased expression of Spp1 mRNA in crowed myeloid cells. Therefore, high hematopoietic cell density in the BM is perceived through E-cadherin, which activates the Hippo pathway to upregulate Spp1 mRNA in myeloid progenitors, eventually limiting their expansion.
The detrimental effects of iOPN in the early stages of emergency granulopoiesis were even clearer during systemic C. albicans infection, which are characterized by a rapid recruitment of neutrophils, essential for clearance of the fungus. Quick generation of neutrophils is achieved through enhanced proliferation of myeloid progenitor cells. Infected OPN − / − mice had a larger GMP population, and showed higher survival than OPN +/+ mice.
Further analyses demonstrated that during emergency granulopoiesis, myeloid progenitor cells, but not CLPs, from OPN +/+ mice downregulated survivin and underwent significantly greater apoptosis than the same progenitor populations from OPN − / − mice. In contrast, apoptosis of CLPs and differentiated myeloid cells was not affected by OPN.
While iOPN appears irrelevant for CLPs and more differentiated T and B lymphocytes, sOPN is a relevant antiapoptotic molecule in T and B cells. Experiments conducted in mice during chronic lymphopenia-induced proliferation, in which OPN could come from adoptively transferred T cells only, showed that sOPN promotes the survival of T cells activated by antigen receptor stimulation. Similar results were obtained when T cells were transferred into OPN +/+ Rag1 − / − (that is, T-and B-cell defective) mice, thus suggesting that sOPN acts in an autocrine fashion. B cells appear to behave similarly. Because T-cell activation induces the production of both iOPN and sOPN, the authors generated a mouse model in which cells can produce iOPN only. Experiments conducted in these mice confirmed that iOPN restrains myeloid progenitor cell expansion, with negligible effects on CLPs. Conversely, sOPN favored expansion of lymphoid cells.
Altogether, these findings suggest that in the early steps of emergency granulopoiesis, an increased release of sOPN, along with steady levels of iOPN in myeloid progenitor cells, protect T and B cells from apoptosis, while restraining excessive expansion of CMPs and GMPs (Figure 1) . Later, low cell density in the BM leads to reduced expression of iOPN and increased generation of monocytes and granulocytes. Additional pathologic conditions need to be investigated to establish if this initial imbalance between lymphoid and myeloid cells is a characteristic of most or only some conditions of emergency granulopoiesis. Further research should also clarify why such a skew is advantageous in these pathologic conditions.
Findings by Kanayama et al. have implications extending beyond emergency granulopoiesis. OPN participates in the pathogenesis of inflammatory and immune-mediated diseases and regulates the host response to infections. 6 Upregulated upon T-cell activation, 7 sOPN favors differentiation toward T helper (Th) type 1 8 and Th type 17 cells, 9 while suppressing Th type 2 cell development. 8 iOPN is an important positive regulator of the Toll-like receptor-mediated expression of interferon alpha in plasmacytoid dendritic cells. iOPN also favors type 17 skew of Th cells by restraining IL-27 production by conventional dendritic cells. 10 In the Nature Immunology paper, the authors also show that sOPN exacerbates T-cell-mediated colitis, 1 thus supporting a role for sOPN in the pathogenesis of autoimmune diseases and intestinal inflammation. 11 OPN is also overexpressed in several malignancies and is associated with metastatic invasion. 12 Interestingly, Sangaletti et al. 13 observed that tumorderived sOPN contributes to tumor aggressiveness by favoring metastasization.
Additionally, iOPN expressed by myeloid-derived suppressor cells favors the establishment of an immunosuppressive milieu in lung metastatic niches. 13 Thus, along with several other ECM proteins, including Tenascin-C 14 and Galectin-3, 15 OPN not only contributes to tumorigenic and metastatic processes, but also exhibits immunosuppressive functions. 
